-transparent.png){kind=logo}
Diabetes in idiopathic hemochromatosis has been considered to be secondary to islet cell damage resulting from the iron deposits. Plasma glucagon was measured by immunoassay using the pancreas specific 30-K antiserum, and was found to be normal or slightly elevated during arginine-infusion tests in patients exhibiting both hemochromatosis and pathological glucose tolerance. This suggests that diabetes in hemochromatosis is not due to a lesion resulting from the iron deposits. The two affections appear to be merely associated and are possibly genetically linked.
Related Publications
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
May 1978,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
September 1977,
Diabetologia,
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
February 1982,
The Journal of clinical endocrinology and metabolism,
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
June 1974,
Diabetes,
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
July 1973,
Horumon to rinsho. Clinical endocrinology,
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
March 2019,
Endocrine,
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
April 2016,
Journal of diabetes and its complications,
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
April 2016,
Journal of hepatology,
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
April 1972,
Helvetica medica acta,
J J Gonvers, and
L Henchoz, and
J R Hofstetter, and
W A Muller
August 1969,
The British journal of surgery,
